ChemoMetec A/S
CHEMM.CO · CPH
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.56 | 0.36 | -2.89 | -6.72 |
| FCF Yield | 0.98% | 0.92% | 1.42% | 0.50% |
| EV / EBITDA | 84.33 | 62.63 | 55.61 | 72.77 |
| Quality | ||||
| ROIC | 12.74% | 17.23% | 11.49% | 14.04% |
| Gross Margin | 96.26% | 91.68% | 90.34% | 89.91% |
| Cash Conversion Ratio | 1.44 | 0.85 | 1.34 | 0.58 |
| Growth | ||||
| Revenue 3-Year CAGR | 22.19% | 25.04% | 29.70% | 36.46% |
| Free Cash Flow Growth | 28.66% | 4.23% | 122.09% | -62.34% |
| Safety | ||||
| Net Debt / EBITDA | -2.87 | -1.96 | -3.28 | -2.52 |
| Interest Coverage | 54.55 | 397.64 | -26.42 | 25.28 |
| Efficiency | ||||
| Inventory Turnover | 0.08 | 0.16 | 0.17 | 0.17 |
| Cash Conversion Cycle | 948.04 | 522.07 | 515.10 | 504.04 |